A Democratic bill with 1 Republican cosponsor · See all 2 cosponsors
Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, titled the "Expanding Seniors' Access to PFAS Testing Act," aims to amend the Social Security Act. It specifically seeks to provide no-cost coverage for PFAS testing under the Medicare program. The legislation defines PFAS testing as a blood test ordered by a physician to determine the concentration of perfluoroalkyl and polyfluoroalkyl substances. This change would apply to testing performed on or after January 1, 2028.
Yes· 3 of 5
- Scored +7
Would people over 65 be better off under this?
The bill provides seniors on Medicare with no-cost coverage for PFAS blood testing starting in 2028.
- Scored +7
Would retired people be better off under this?
The bill eliminates cost-sharing for PFAS testing for those covered under the Medicare program.
- Scored +6
Does this make health care easier to get in general?
The bill makes blood testing for PFAS concentration more accessible by removing cost-sharing for Medicare beneficiaries.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
No-cost coverage for testing: Under Section 2(b), Medicare would pay 100 percent of the lesser of the actual charges or the determined fee schedule for PFAS testing performed on or after January 1, 2028. This provides a financial benefit to individuals by removing cost-sharing for these specific blood tests.
-
Access to specific diagnostic information: Section 2(a) defines "PFAS testing" as a blood test ordered by a physician to determine the concentration of perfluoroalkyl and polyfluoroalkyl substances. This allows Medicare beneficiaries to have these specific concentrations determined through a physician-ordered test.
Potential Negative Impacts for People
- No negative impacts are explicitly stated in the text of the bill provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would retired people be better off under this? — The bill eliminates cost-sharing for PFAS testing for those covered under the Medicare program. Would people over 65 be better off under this? — The bill provides seniors on Medicare with no-cost coverage for PFAS blood testing starting in 2028. Would households on low incomes be better off under this? — The bill reduces financial burdens for low-income seniors who rely on Medicare for healthcare services.
- Healthcare
- Does this make health care easier to get in general? — The bill makes blood testing for PFAS concentration more accessible by removing cost-sharing for Medicare beneficiaries. Does this put more money into Medicare, the health coverage for people over 65? — The bill expands Medicare coverage to include 100 percent of the cost for PFAS testing.
- 11/21/2025
- 1 Cosponsor added.
- 9/26/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 1 Cosponsor added.
- Introduced in House
Brian FitzpatrickRepublican · Pennsylvania
Kristen McDonald RivetDemocrat · Michigan